Interestingly, the phospho-activation signatures for each drug were not identical and patients on LEF exhibited reductions in p-STAT6 in their CD20+ B cells and reduced p-PLC-c in their CD4+ and CD8+ T cells
p-JNK/p-p38 ratio .one.5 was observed in 80% (4/five), sixty% (3/five) and eighty% (four/five) of...